BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32242086)

  • 1. Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder.
    Liu H; Zimmerman AW; Singh K; Connors SL; Diggins E; Stephenson KK; Dinkova-Kostova AT; Fahey JW
    Sci Rep; 2020 Apr; 10(1):5822. PubMed ID: 32242086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane Treatment of Young Men with Autism Spectrum Disorder.
    Singh K; Zimmerman AW
    CNS Neurol Disord Drug Targets; 2016; 15(5):597-601. PubMed ID: 27071786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
    Liu H; Talalay P; Fahey JW
    CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey.
    Kutuk MO; Tufan E; Gokcen C; Kilicaslan F; Karadag M; Mutluer T; Yektas C; Coban N; Kandemir H; Buber A; Coskun S; Acikbas U; Guler G; Topal Z; Celik F; Altintas E; Giray A; Aka Y; Kutuk O
    Cytokine; 2020 Sep; 133():155152. PubMed ID: 32563959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alsaad AMS; Assiri MA; Al-Mazroua HA; Attia SM
    J Neuroimmunol; 2020 Dec; 349():577430. PubMed ID: 33130460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.
    Abruzzo PM; Matté A; Bolotta A; Federti E; Ghezzo A; Guarnieri T; Marini M; Posar A; Siciliano A; De Franceschi L; Visconti P
    J Transl Med; 2019 Oct; 17(1):332. PubMed ID: 31578139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized cell-free DNA as a stress-signaling factor activating the chronic inflammatory process in patients with autism spectrum disorders.
    Shmarina GV; Ershova ES; Simashkova NV; Nikitina SG; Chudakova JM; Veiko NN; Porokhovnik LN; Basova AY; Shaposhnikova AF; Pukhalskaya DA; Pisarev VM; Korovina NJ; Gorbachevskaya NL; Dolgikh OA; Bogush M; Kutsev SI; Kostyuk SV
    J Neuroinflammation; 2020 Jul; 17(1):212. PubMed ID: 32677958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):472-480. PubMed ID: 28802860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated IL-16 expression is associated with development of immune dysfunction in children with autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Psychopharmacology (Berl); 2019 Feb; 236(2):831-838. PubMed ID: 30456538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipidomics of peripheral blood mononuclear cells (PBMCs): the tricky case of children with autism spectrum disorder (ASD) and their healthy siblings.
    Ventura G; Calvano CD; Porcelli V; Palmieri L; De Giacomo A; Xu Y; Goodacre R; Palmisano F; Cataldi TRI
    Anal Bioanal Chem; 2020 Oct; 412(25):6859-6874. PubMed ID: 32737553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children.
    Nadeem A; Ahmad SF; Attia SM; Bakheet SA; Al-Harbi NO; Al-Ayadhi LY
    Brain Behav Immun; 2018 Jan; 67():335-344. PubMed ID: 28935156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha expression in peripheral blood mononuclear cells correlates with early childhood social interaction in autism spectrum disorder.
    Makinodan M; Iwata K; Ikawa D; Yamashita Y; Yamamuro K; Toritsuka M; Kimoto S; Okumura K; Yamauchi T; Yoshino H; Tsujii M; Sugiyama T; Tsuchiya K; Mori N; Matsuzaki H; Kishimoto T
    Neurochem Int; 2017 Mar; 104():1-5. PubMed ID: 28007470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of miR-181b-5p, miR-23a-3p, BCL-2, and IL-6 in Peripheral Blood Mononuclear Cells of Autistic Patients; Likelihood of Reliable Biomarkers.
    Atwan H; Assarehzadegan MA; Shekarabi M; Jazayeri SM; Barfi S; Shokouhi Shoormasti R; Chimeh N; Pouretemad HR; Tayebi B
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):74-83. PubMed ID: 32245323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients.
    Pecorelli A; Cervellati F; Belmonte G; Montagner G; Waldon P; Hayek J; Gambari R; Valacchi G
    Cytokine; 2016 Jan; 77():180-8. PubMed ID: 26471937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():98-104. PubMed ID: 29698674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude.
    Saghazadeh A; Ataeinia B; Keynejad K; Abdolalizadeh A; Hirbod-Mobarakeh A; Rezaei N
    J Psychiatr Res; 2019 Aug; 115():90-102. PubMed ID: 31125917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alotaibi MR; Alhoshani AR; Alshammari MA; Attia SM
    Mol Immunol; 2019 Feb; 106():77-86. PubMed ID: 30590210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial.
    Ou J; Smith RC; Tobe RH; Lin J; Arriaza J; Fahey JW; Liu R; Zeng Y; Liu Y; Huang L; Shen Y; Li Y; Cheng D; Cornblatt B; Davis JM; Zhao J; Wu R; Jin H
    J Autism Dev Disord; 2024 Feb; 54(2):628-641. PubMed ID: 36427174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
    Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children With Autism Spectrum Disorder and Their Mothers Share Abnormal Expression of Selected Endogenous Retroviruses Families and Cytokines.
    Balestrieri E; Cipriani C; Matteucci C; Benvenuto A; Coniglio A; Argaw-Denboba A; Toschi N; Bucci I; Miele MT; Grelli S; Curatolo P; Sinibaldi-Vallebona P
    Front Immunol; 2019; 10():2244. PubMed ID: 31616420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.